Phosphorous Dendrimers in Biology and Nanomedicine

Anne-Marie Caminade is director of research (exceptional class) at the CNRS in Toulouse, France, and head of the Dendrimers and Heterochemistry research group. Her current research interest is in dendrimers. She has authored or coauthored more than 430 articles in peer-reviewed journals (including around 380 articles on dendrimers), 40 book chapters, 1 book, and 15 patents and has participated in 150 invited conferences. Cédric-Olivier Turrin is a CNRS research scientist at the Laboratoire de Chimie de Coordination, Toulouse, France. His research interests are focused on the design of hyperbranched phosphorus-containing architectures, including dendrimers, and their uses in biomedicine and nanosciences. Jean-Pierre Majoral is emeritus director of research at the CNRS in Toulouse. His current research interest is focused on the design and properties of phosphorus dendrimers in nanomedicine, materials sciences, and catalysis. He is a member of several academies of sciences worldwide, cofounder of the company Dendris, and an author of more than 610 publications, 5 books, 28 book chapters, and 40 patents.

Syntheses of Phosphorus Dendrimers. Methods for Characterizing (Phosphorus) Dendrimers. EPR Characterization of Phosphorous Dendrimers as Drugs for Cancer and Neurodegenerative Diseases. Fluorescent (Phosphorus) Dendrimers and Their Use for Biology. Biomaterials Made of Phosphorus Dendrimers: Towards Diagnosis Tools. PPH-Based Dendrimers as HIV Entry Inhibitors. Role of Dendrimers in the Development of New Dendritic Cells Immunotherapies against HIV-1 Infection. Phosphorus Dendrimers as Vectors for Gene Therapy in Cancer. First-in-Class Anticancer Nanoparticle Copper(II) Phosphorus Dendrimers as Proapoptotic Bax Activators. Rational Design of Mannodendrimers Targeting Human C-Type Lectin Receptors to Prevent Lung Inflammation. Phosphorus-Containing Dendrimers against Diseases of the Central Nervous System. The ABP Dendrimer Saga. Dendrimer Space Concept: A Futuristic Vision in Nanomedicine to Develop New Drugs. DNA-Based Multiplexing Technology for Rapid and Accurate Diagnosis of Pathogens: An Original Contribution of Phosphorus Dendrimers.